Filing Details
- Accession Number:
- 0001104659-20-080639
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-02 16:46:48
- Reporting Period:
- 2020-06-30
- Accepted Time:
- 2020-07-02 16:46:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1649904 | Rhythm Pharmaceuticals Inc. | RYTM | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1315082 | Ra Capital Healthcare Fund Lp | C/O Ra Capital Management, L.p. 200 Berkeley Street, 18Th Floor Boston MA 02116 | No | No | Yes | No | |
1346824 | Ra Capital Management, L.p. | 200 Berkeley Street, 18Th Floor Boston MA 02116 | No | No | Yes | No | |
1384859 | Peter Kolchinsky | C/O Ra Capital Management, L.p. 200 Berkeley Street, 18Th Floor Boston MA 02116 | No | No | Yes | No | |
1619841 | M. Rajeev Shah | C/O Ra Capital Management, L.p. 200 Berkeley Street, 18Th Floor Boston MA 02116 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-06-30 | 61,901 | $22.15 | 5,210,088 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2020-07-01 | 25,527 | $21.87 | 5,184,561 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2020-07-02 | 44,153 | $22.04 | 5,140,408 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $21.90 to $22.41; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- RA Capital Management, L.P. (the "Adviser") is the investment manager for the RA Capital Healthcare Fund, L.P. (the "Fund") and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah may be deemed indirect beneficial owners of the reported securities for purposes of Section 13(d) of the Securities Exchange Act of 1934 (the "Act").
- They disclaim beneficial ownership of any of the reported securities for the purpose of determining whether they are subject to Section 16 of the Act, however, in reliance on Rule 16a-1(a)(1)(v) and (vii). To the extent that they might be deemed subject to Section 16, they disclaim beneficial ownership of securities held by the Fund for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein, and disclaim any pecuniary interest in securities held in the Account for purposes of Rule 16a-1(a)(2).
- The filing of this Form 4 shall not be construed as an admission that either the Adviser, the Adviser GP, Dr. Kolchinsky, or Mr. Shah is or was for the purposes of Section 16(a), or otherwise, the beneficial owner of any of the securities held in the Account.
- This transaction was executed in multiple trades at prices ranging from $21.75 to $22.09; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- This transaction was executed in multiple trades at prices ranging from $22.00 to $22.165; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- Includes 4,599,403 shares held by the Fund and 541,005 shares held by the Account.